Aspire Biopharma completes $30 million acquisition of Dura Driver Control Systems

Reuters2026/08/10 12:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aspire Biopharma completed its acquisition of Dura Driver Control Systems, buying 100% of the shares for about USD 30 million cash.
Funding included a new USD 22.5 million senior secured revolving credit facility, supplemented by cash on hand.
Dura Driver Control Systems reported USD 209.5 million revenue, USD 22.3 million adjusted EBITDA for 2025.
For the six months ended June 30, 2026, DCS generated about USD 103.9 million revenue, USD 10.5 million adjusted EBITDA.
DCS CEO Hans Vorstenbosch remains in charge of the unit, with the existing management team.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608100830ACCESSWRNAPR_____1205431) on August 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Aspire Biopharma completes $30 million acquisition of Dura Driver Control Systems

You may also like

Crypto prices